Posted by Michael Wonder on 26 Oct 2023
First NICE recommended treatment for Parkinson’s set to benefit hundreds
26 October 2023 - Around 900 adults with advanced Parkinson’s are set to benefit from new treatment foslevodopa–foscarbidopa after NICE approved it for NHS use in final draft guidance published today.
NICE has recommended foslevodopa–foscarbidopa (Produodopa; AbbVie) as an option for treating advanced Parkinson’s, a progressive disorder that affects the nervous system and the parts of the body controlled by the nerves.
